Wes Burk, cofounder and vice president of Emerald Scientific, discusses this year's Emerald Conference, some of Emerald’s other initiatives in cannabis science, and their plans going into 2020
John S. Abrams, PhD, discusses some of the cutting-edge work he’s involved in and what he’s looking forward to at this year's Emerald Conference.
NMU and SSI collaborated to establish the Shimadzu Analytical Core Laboratory for Medicinal Plant Sciences for NMU’s undergraduate degree program in medicinal plant chemistry.
On Tuesday, December 3, 2019, Brazil’s pharmaceutical regulator Avinsa approved regulations for the roll-out of medicinal cannabis-based products.
November 20, 2019 marked a monumental day in the prohibition of cannabis. The House Judiciary Committee (1) approved a bill that would federally decriminalize cannabis by removing it from the Controlled Substance Act and expunge particular crimes related to marijuana.
From 9/11 First Responder to Cancer Survivor and Cannabis Entrepreneur: How One Man’s Cannabis Journey Is Impacting the Medicinal Field
Aryn Sieber, the founder and CEO of CBD Essentials and Cannaisseur Brands as well as the founder of CannaCauses Foundation, discusses his experiences as a 9/11 first responder, his battle with stage IV cancer, and how cannabis impacted his life.
Dr. Andrea Holmes discusses how she’s using colorimetric analysis to discover novel minor cannabinoids, the potential role of smartphone compatibility in detection, what’s next for cannabinoid research, and more.